This podcast is produced by pharmacy faculty to supplement study material and provide relevant drug and professional topics. We're hoping that our real-life clinical pearls and discussions will help you stay up-to-date and improve your pharmacy knowledge.
HelixTalk - Rosalind Franklin University's College of Pharmacy Podcast
Claim This Podcastby Sean P. Kane, PharmD; Khyati Patel, PharmD
4.9(765 reviews)
212 episodes
Updated Bi-weekly
Accepts GuestsHas SponsorsLocation 🇺🇸
65
Podcast Authority
BetaGoodBased on show quality, social media presence, reviews, charts, and more
Quality92
Social0
YouTube0
Engagement97
Podcast Overview
This podcast is produced by pharmacy faculty to supplement study material and provide relevant drug and professional topics. We're hoping that our real-life clinical pearls and discussions will help you stay up-to-date and improve your pharmacy knowledge.
Language
🇺🇲
Publishing Since
3/5/2014
Unlock The Full Podcast Authority Score Report
See how your podcast performs across key metrics
65
Podcast Authority
BetaGoodBased on show quality, social media presence, reviews, charts, and more
Quality92
Social0
YouTube0
Engagement97
9
Excellent Areas
1
Good Performance
9
Growth Opportunities
excellent
Episode Length
40 minutes
Performing excellently!
good
iTunes Tags
7.2/10
Recommendations available
Unlock the full report to see detailed tips
needs improvement
Publishing Consistency
Every 20 days
Recommendations available
Unlock the full report to see detailed tips
+16 More Metrics
Unlock comprehensive insights including:
- • YouTube presence analysis
- • Social media reach metrics
- • RSS compliance scoring
- • Podcast 2.0 features
- • Technical standards
What's Included in Your Full Report
Detailed Analytics
- Complete breakdown of all 19 authority metrics
- Personalized recommendations for each metric
- Industry benchmarks and comparisons
- Technical RSS feed analysis and compliance scoring
Growth Strategies
- Step-by-step action plans for improvement
- Quick wins to boost your score immediately
- Pro tips from successful podcasters
Get your free podcast insights report
See how your show performs across every key metric
Instant delivery
No spam
Attract Better Guests
High authority scores make your podcast more attractive to industry leaders and influencers who want to appear on credible shows.
Secure Sponsorships
Sponsors look for podcasts with proven authority and engagement. Your score demonstrates your podcast's value to potential partners.
Grow Your Audience
Understanding your strengths and weaknesses helps you make data-driven decisions to expand your listener base effectively.
1 verified contact email on file for HelixTalk - Rosalind Franklin University's College of Pharmacy Podcast
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
Recent Episodes
June 4, 2026
198 - Lp(a), ApoB, and CAC: Navigating the 2026 Dyslipidemia Guideline Alphabet Soup
Host Dr. [Host Last Name] and guest Dr. [Guest Last Name] explore the 2026 dyslipidemia guidelines, clarifying Lp(a), ApoB, and CAC for better cardiovascular risk assessment.
April 3, 2026
197 - Sweet Deal of Updates in Diabetes Pharmacotherapy from the ADA 2026 Standards of Care
<p>In this episode, we discuss the most important annual updates in the American Diabetes Association Guidelines, Standards of Care 2026, particularly focusing on changes in pharmacotherapy recommendations and the supporting evidence.</p> <p><strong>Key Concepts</strong></p> <ol> <li>A few existing agents now have ASCVD risk reduction data in patients with existing ASCVD or high indicators for ASCVD. They are: oral semaglutide and tirzepatide. </li> <li>SGLT2is are still first-line in patients with diabetes and HF including HFpEF, but SC semaglutide and tirzepatide are now recommended for those with symptomatic HFpEF and obesity due to positive outcomes in this population.</li> <li>The GLP-1RA and dual GLP-1/GIP RA are the preferred agents for weight management in patients with T2DM, but use of GLP-1RA can be considered for weight loss in patients with T1DM.</li> <li>The guideline also better defines recommendations for medication-induced hyperglycemia from immune checkpoint inhibitors, PI3Kɑ (phosphoinositidylinositol 3-kinase α) inhibitors, mTOR inhibitors, and steroids. </li> </ol> <p><strong>References</strong></p> <ul> <li>American Diabetes Association. Standards of care in diabetes—2026. Diabetes Care. 2026;49(suppl 1):S1-S377.</li> <li>SOUL study. Darren K. McGuire, Marx N, Mulvagh SL, et al. Oral semaglutide and cardiovascular outcomes in high-risk type 2 diabetes. N Engl J Med. 2025;392(20):2001-2012. doi:10.1056/NEJMoa2501006.</li> <li>SURPASS-CVOT. Nicholls SJ, Pavo I, Bhatt DL, et al. Cardiovascular outcomes with tirzepatide versus dulaglutide in type 2 diabetes. N Engl J Med. 2025;393(24):2409-2420. doi:10.1056/NEJMoa2505928.</li> <li>SUMMIT. Packer M, Zile MR, Kramer CM, et al. Tirzepatide for heart failure with preserved ejection fraction and obesity. N Engl J Med. 2025;392(5):427-437. doi:10.1056/NEJMoa2410027.</li> <li>STEP-HFpEF. Kosiborod MN, Abildstrom SZ, Borlaug BA, et al. Semaglutide in patients with heart failure with preserved ejection fraction and obesity. N Engl J Med. 2023;389(12):1069-1084. doi:10.1056/NEJMoa2306963.</li> <li>STEP-HFpEF DM. Kosiborod MN, Petrie MC, Borlaug BA, et al. Semaglutide in patients with obesity‑related heart failure and type 2 diabetes. N Engl J Med. 2024;390(15):1394‑1407. doi:10.1056/NEJMoa2313917.</li> </ul>
March 18, 2026
196 - Stretching the Stroke Clock to 2026: A Brief Review of the 2026 Acute Ischemic Stroke Guidelines
Host Dr. Krystal Zachrison reviews the 2026 acute ischemic stroke guidelines, detailing updated thrombolysis, antiplatelet, and blood pressure management strategies for improved patient outcomes.
212 total episodes available with 4 transcripts
Similar Podcasts
Discover related shows you might enjoy
Real Life Pharmacology - Pharmacology Education for Health Care Professionals
Eric Christianson, PharmD; Pharmacology Expert and Clinical Pharmacist
The Curbsiders Internal Medicine Podcast
The Curbsiders Internal Medicine Podcast
Core IM | Internal Medicine Podcast
Core IM Team
Critical Care Time
Critical Care Time Podcast
JAMA Clinical Reviews
JAMA Network
Emergency Medical Minute
Emergency Medical Minute
Core EM - Emergency Medicine Podcast
Core EM
CorConsult Rx: Evidence-Based Medicine and Pharmacy
Mike Corvino, PharmD, BCPS, BCACP, CDCES and Cole Swanson, PharmD, CDCES
Up First
NPR
The Mel Robbins Podcast
Mel Robbins
On Purpose with Jay Shetty
iHeartPodcasts
Apple News Today
Apple News
Morbid
Ash Kelley & Alaina Urquhart
Crime Junkie
Audiochuck
The Elective Rotation: A Critical Care Hospital Pharmacy Podcast
Pharmacy Joe
Deep-dive analytics for HelixTalk - Rosalind Franklin University's College of Pharmacy Podcast
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is HelixTalk - Rosalind Franklin University's College of Pharmacy Podcast?
- How often does this podcast release new episodes?
This podcast updates bi-weekly.
- Where can I listen to this podcast?
This podcast is available on 10 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
Yes, this podcast regularly features guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.